(ECNS) -- China completed the implantation of an approved brain-computer interface (BCI) device on Monday, following the March market approval of the system, known as Neural Electronic Opportunity (NEO).
The first prescription for NEO, an implantable BCI hand motor function compensation system, was issued in Shanghai, where the surgery was performed at Huashan Hospital, which is affiliated with Fudan University.
The patient remains in stable condition after the surgery, and intraoperative tests showed that the epidural electroencephalogram (EEG) signals collected by the system were stable and of good quality, according to the hospital.
Once limited to laboratories and clinical trials, the cutting-edge technology received market approval on March 13, becoming the world's first implantable BCI to be approved as a Class III medical device.
(By Kira)
















































京公网安备 11010202009201号